Novo Nordisk's SWOT analysis: obesity drug leader faces supply hurdles
A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...
Celestica's SWOT analysis: AI boom propels stock to new heights
Celestica Inc . (NYSE:CLS; TSX:CLS), a leading provider of supply chain solutions and electronics manufacturing services (EMS) with a market capitalization of over $10 billion, has been riding a wave ...